Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier organic anion transporter family member 3A1 (OATP3A1) is a transmembrane transporter protein of the solute carrier (SLC) superfamily, encoded by the SLCO3A1 gene in humans. It is characterized by broad substrate specificity, transporting various organic anions, including prostaglandins (PGE1, PGE2), bile acids (taurocholate, glycocholate, glycochenodeoxycholate), thyroid hormones (L-thyroxine), and peptide hormones (such as vasopressin). The protein localizes to plasma membranes, including the basal and apical membranes, and may function in a tissue-specific manner. OATP3A1 is notably upregulated in cholestatic liver disease, serving as a bile acid efflux transporter under cholestatic stress, and has been implicated in maintaining bile acid homeostasis. Dysregulation or knockout of this transporter in animal models results in impaired hepatic bile acid clearance and increased susceptibility to liver injury. The gene has also been associated with other disorders, including intestinal perforation and primary hypertrophic osteoarthropathy. At present, there are no therapeutically approved drugs specifically targeting OATP3A1, but drug interactions are possible via altered transport of substrate drugs or endogenous substances[1][2][3][4].
Inhibition or modulation of substrate (organic anion, prostaglandin, bile acid, thyroid hormone) transport across cell membranes\nPossible impact on bile acid homeostasis and prostaglandin-mediated signaling
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier organic anion transporter family member 3A1 (OATP3A1).